Germering, Germany

Ursula Zimber-Strobl

This inventor holds 1 USPTO granted patent. Top assignee: Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ursula Zimber-Strobl

Introduction

Ursula Zimber-Strobl is a notable inventor based in Germering, Germany. She has made significant contributions to the field of immunology, particularly in the stimulation of T cells with desired antigen specificity. Her work has implications for therapeutic strategies in cancer and other diseases.

Latest Patents

Ursula Zimber-Strobl holds a patent for a method that enhances the stimulation of T cells having a desired antigen specificity. The patent outlines a multi-step process that includes introducing immortalizing genes into antigen-presenting cells, expanding these cells, and cultivating them with T cells to stimulate the desired immune response. This innovative approach has the potential to improve the efficacy of T cell-based therapies.

Career Highlights

Zimber-Strobl is affiliated with the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, where she conducts her research. Her work has been recognized for its impact on understanding T cell behavior and its applications in medical science. She has a strong focus on developing methods that can be utilized in clinical settings.

Collaborations

Throughout her career, Ursula has collaborated with esteemed colleagues such as Georg W. Bornkamm and Axel Polack. These collaborations have enriched her research and contributed to advancements in the field of immunology.

Conclusion

Ursula Zimber-Strobl's innovative work in T cell stimulation represents a significant advancement in immunological research. Her contributions continue to pave the way for new therapeutic approaches in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…